Brazil reviews malaria facilities, invests in equipment
This article was originally published in Clinica
Brazilian healthcare authorities are investing in malaria diagnostics equipment, following a review of the facilities developed under the national malaria control programme (PNCM), launched in 2003. The scale of the programme is impressive: there are 2,860 malaria diagnostics laboratories in 805 municipalities, supported by over 14,000 notification units and almost 37,000 staff (excluding doctors and other clinical care staff). The programme has so far resulted in a significant fall in incidence rate, from 31.9 per 1,000 inhabitants in 1999, to 18.3 per 1,000 in 2003, and a fall in case fatality rate, from 0.30 to 0.23 per 1,000 cases, over the same period.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.